Teleflex Incorporated (NYSE:TFX) Shares Sold by Congress Asset Management Co.

Congress Asset Management Co. trimmed its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 27.6% in the fourth quarter, Holdings Channel reports. The firm owned 1,503 shares of the medical technology company’s stock after selling 573 shares during the period. Congress Asset Management Co.’s holdings in Teleflex were worth $268,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of TFX. Simplify Asset Management Inc. acquired a new stake in shares of Teleflex during the third quarter valued at about $4,800,000. JPMorgan Chase & Co. boosted its position in shares of Teleflex by 14.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after purchasing an additional 19,466 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its holdings in Teleflex by 5.2% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock valued at $19,263,000 after purchasing an additional 5,322 shares during the last quarter. Lecap Asset Management Ltd. purchased a new stake in Teleflex in the fourth quarter valued at approximately $729,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its position in Teleflex by 35.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock valued at $1,053,000 after purchasing an additional 1,527 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of research reports. Truist Financial dropped their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Mizuho cut their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Finally, StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Stock Up 1.1 %

TFX stock opened at $169.33 on Wednesday. Teleflex Incorporated has a fifty-two week low of $165.62 and a fifty-two week high of $253.06. The company’s 50 day moving average price is $177.75 and its 200 day moving average price is $208.74. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm has a market capitalization of $7.86 billion, a price-to-earnings ratio of 33.66, a PEG ratio of 1.72 and a beta of 1.16.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.